Zhain Mustufvi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhain Mustufvi has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Kulveer Mankia
Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds , Leeds
2 shared publications - Stefan Serban
School of Medicine, Dentistry, and Nursing, University of Glasgow, Glasgow, UK
2 shared publications Aradhna Tugnait
School of Dentistry, University of Leeds
1 shared publicationGail Douglas
School of Dentistry, University of Leeds, Leeds, UK
1 shared publicationJames Chesterman
Leeds Teaching Hospitals NHS Trust
1 shared publication- James Chesterman
Leeds Dental Institute, Leeds Teaching Hospitals NHS Trust, Worsley Building, Clarendon Way, Leeds LS2 9LU, UK
1 shared publication
Latest Publications
- Open Access
- 17 August 2022
- Published by Oxford University Press (OUP) in Rheumatology Advances in Practice
- Vol. 6 (2) , rkac061
Does periodontal treatment improve rheumatoid arthritis disease activity? A systematic review
What does this mean for patients? This review found 21 research trials that investigated the effect of treatment of gum disease on rheumatoid arthritis. The key finding was that treating gum disease in people who have rheumatoid arthritis improves the DAS-28, which is a measure of the severity of the rheumatoid arthritis. This is important, because rheumatoid arthritis is incurable and has a significant impact on quality of life. Furthermore, gum disease is more prevalent in people with rheumatoid arthritis and, if untreated, can lead to pain, infection and premature tooth loss. This review highlighted several limitations of the included trials. In addressing these limitations, the review makes important recommendations for future research on this topic to ensure further high-quality findings. Finally, this review makes a strong case that rheumatologists, dentists and people who are affected by rheumatoid arthritis should have a heightened awareness of the link between these two diseases. Screening and treating gum disease should form part of the normal care pathway for people with rheumatoid arthritis.
- 17 August 2022
- Published by Oxford University Press (OUP) in Rheumatology Advances in Practice
- Vol. 6 (2) , rkac061
Open AccessDoes periodontal treatment improve rheumatoid arthritis disease activity? A systematic review
What does this mean for patients? This review found 21 research trials that investigated the effect of treatment of gum disease on rheumatoid arthritis. The key finding was that treating gum disease in people who have rheumatoid arthritis improves the DAS-28, which is a measure of the severity of the rheumatoid arthritis. This is important, because rheumatoid arthritis is incurable and has a significant impact on quality of life. Furthermore, gum disease is more prevalent in people with rheumatoid arthritis and, if untreated, can lead to pain, infection and premature tooth loss. This review highlighted several limitations of the included trials. In addressing these limitations, the review makes important recommendations for future research on this topic to ensure further high-quality findings. Finally, this review makes a strong case that rheumatologists, dentists and people who are affected by rheumatoid arthritis should have a heightened awareness of the link between these two diseases. Screening and treating gum disease should form part of the normal care pathway for people with rheumatoid arthritis.
- Open Access
- 5 October 2021
- Published by MDPI AG in Healthcare
- Vol. 9 (10) , 1326
Should We Be Screening for and Treating Periodontal Disease in Individuals Who Are at Risk of Rheumatoid Arthritis?
There is increasing evidence supporting an association between periodontal disease (PD) and rheumatoid arthritis (RA), both mechanistically and clinically. Trials have shown that treating PD in people with RA may improve RA disease activity. Patients with musculoskeletal symptoms without arthritis, who test positive for cyclic-citrullinated protein antibodies, are at risk of RA (CCP+ at-risk), with seropositivity preceding arthritis onset by months or years. Importantly, there is evidence to suggest that periodontal inflammation may precede joint inflammation in CCP+ at-risk and, therefore, this could be a trigger for RA. There has been increased research interest in RA prevention and the phenotyping of the pre-RA disease phase. This review will examine the merits of identifying individuals who are CCP+ at-risk and performing screening for PD. In addition, we discuss how PD should be treated once identified. Finally, the review will consider future research needed to advance our understanding of this disease association.
- 5 October 2021
- Published by MDPI AG in Healthcare
- Vol. 9 (10) , 1326
Open AccessShould We Be Screening for and Treating Periodontal Disease in Individuals Who Are at Risk of Rheumatoid Arthritis?
There is increasing evidence supporting an association between periodontal disease (PD) and rheumatoid arthritis (RA), both mechanistically and clinically. Trials have shown that treating PD in people with RA may improve RA disease activity. Patients with musculoskeletal symptoms without arthritis, who test positive for cyclic-citrullinated protein antibodies, are at risk of RA (CCP+ at-risk), with seropositivity preceding arthritis onset by months or years. Importantly, there is evidence to suggest that periodontal inflammation may precede joint inflammation in CCP+ at-risk and, therefore, this could be a trigger for RA. There has been increased research interest in RA prevention and the phenotyping of the pre-RA disease phase. This review will examine the merits of identifying individuals who are CCP+ at-risk and performing screening for PD. In addition, we discuss how PD should be treated once identified. Finally, the review will consider future research needed to advance our understanding of this disease association.
- 10 February 2020
- Published by Springer Nature in BDJ In Practice
- Vol. 33 (2) , 20-22
Flexible Commissioning: A prevention and access focused approach in Yorkshire and the Humber
- 10 February 2020
- Published by Springer Nature in BDJ In Practice
- Vol. 33 (2) , 20-22
Flexible Commissioning: A prevention and access focused approach in Yorkshire and the Humber